Market Overview

Boston Scientific Receives CE Mark Approval for X4 Quadripolar CRT-D Systems

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval of its X4 line of quadripolar CRT-D systems, including the AUTOGEN™ X4, DYNAGEN™ X4, and INOGEN™ X4 cardiac resynchronization therapy defibrillators (CRT-Ds), a suite of ACUITY™ X4 quadripolar LV leads and the ACUITY™ PRO lead delivery system.  The company's latest devices to treat heart failure and sudden cardiac arrest are designed to advance patient care and improve the implant experience. 

See full press release

Posted-In: News Guidance Contracts Management Global


Most Popular

Related Articles (BSX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free